BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: TrueCar, Inc. (Nasdaq – TRUE), Astria Therapeutics, Inc. (Nasdaq – ATXS), PotlatchDeltic Corporation (Nasdaq – PCH), SWK Holdings Corporation (Nasdaq – SWKH)

BALA CYNWYD, Pa., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.

TrueCar, Inc. (Nasdaq – TRUE)

Under the terms of the Merger Agreement, TrueCar will be acquired by Fair Holdings, Inc. (“Fair Holdings”), an entity led by TrueCar founder Scott Painter. Fair Holdings will acquire the Company in an all-cash, go-private transaction at $2.55 per share, or an equity value of approximately $227 million. The investigation concerns whether the TrueCar Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal consideration provides fair value to the Company’s shareholders.

Additional information can be found at https://www.brodskysmith.com/cases/truecar-inc-nasdaq-true/.

Astria Therapeutics, Inc. (Nasdaq – ATXS)

Under the terms of the Merger Agreement, Astria will be acquired by BioCryst Pharmaceuticals, Inc. (Nasdaq – BCRX) for a mix of cash and stock representing an implied value of $13.00 per Astria share, and approximately $700 million in enterprise value. The investigation concerns whether the Astria Therapeutics Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal consideration provides fair value to the Company’s shareholders.

Additional information can be found at https://www.brodskysmith.com/cases/astria-therapeutics-inc-nasdaq-atsx/.

PotlatchDeltic Corporation (Nasdaq – PCH)

Under the terms of the Merger Agreement, PotlatchDeltic will be acquired by Rayonier (NYSE – RYN). PotlatchDeltic shareholders will receive 1.7339 common shares of Rayonier for each share of common stock of PotlatchDeltic. The exchange ratio represents an implied price of $44.11 per PotlatchDeltic share. The investigation concerns whether the PotlatchDeltic Corporation Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal consideration provides fair value to the Company’s shareholders.

Additional information can be found at visit https://www.brodskysmith.com/cases/potlatchdeltic-corporation-nasdaq-pch/.

SWK Holdings Corporation (Nasdaq – SWKH)

Under the terms of the Merger Agreement, SWK will be acquired by Runway Growth Finance Corp. (Nasdaq – RWAY) in a net asset value (“NAV”)-for-NAV merger and will have an estimated purchase price of approximately $220 million. This includes a fixed stock component expected to total $75.5 million in Runway Growth shares valued at closing NAV per share and approximately $145 million in cash. The cash payment will be based on SWK's final NAV. Additionally, Runway Growth Capital LLC, in its capacity as Runway Growth's external investment adviser, will be contributing $9 million in cash for distribution as consideration to the stockholders of SWK separate from and in addition to the consideration. The investigation concerns whether the SWK Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal consideration provides fair value to the Company’s shareholders.

Additional information can be found at https://www.brodskysmith.com/cases/swk-holdings-corporation-nasdaq-swkh/.

Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.